Controlled Substances Regulations (SOR/2025-242)

Marginal note:Sale to individual

• The following provision is not in force.

  98 (1) A pharmacist may sell or provide a controlled substance to an individual if

  • The following provision is not in force.

    (a) the sale or provision is for the individual’s own use, for the use of another individual or for an animal;

  • The following provision is not in force.

    (b) the controlled substance is in the form of a finished product that does not contain a restricted drug; and

  • The following provision is not in force.

    (c) subject to subsection (2), the pharmacist first receives the following in respect of the controlled substance from one of the following persons:

    • (i) in the case of the individual, a written prescription,

    • (ii) in the case of another pharmacist or a pharmacy technician,

      • (A) a written prescription, or

      • (B) a copy of the document on which the information with respect to a verbal prescription has been recorded under section 117, or

    • (iii) in the case of a practitioner, a written or verbal prescription.

• The following provision is not in force.

  Marginal note:Finished product containing low dose of codeine

  (2) A pharmacist may sell or provide, without a prescription, a finished product containing codeine phosphate to an individual if

  • The following provision is not in force.

    (a) the finished product contains

    • (i) in the case of a finished product in solid form, not more than 8 mg or its equivalent of codeine phosphate per unit, or

    • (ii) in the case of a finished product in liquid form, not more than 20 mg or its equivalent of codeine phosphate per 30 mL;

  • The following provision is not in force.

    (b) the finished product contains

    • (i) two additional medicinal ingredients other than a narcotic in a quantity of not less than the regular minimum single dose for one such ingredient or one-half of the regular minimum single dose for each such ingredient, or

    • (ii) three additional medicinal ingredients other than a narcotic in a quantity of not less than the regular minimum single dose for one such ingredient or one-third of the regular minimum single dose for each such ingredient;

  • The following provision is not in force.

    (c) the pharmacist has reasonable grounds to believe that the finished product will only be used for recognized medical purposes; and

  • The following provision is not in force.

    (d) the pharmacist ensures that the following caution or its equivalent is conspicuously and legibly printed on the finished product’s inner label and outer label, as those terms are defined in section A.01.010 of the Food and Drug Regulations:

  The following provision is not in force.

  “This product contains codeine and should not be administered to children except on the advice of a physician, dentist or nurse practitioner.”